Back to Top Skip to main content Skip to sub-navigation

Military nurses hold virtual research & evidence-based practice course

Two nurses, wearing masks, examining a mannequin Navy Hospital Corpsman 2nd Class Meghan Audibert (left), and Carla Henley, a registered nurse (right), both assigned to Naval Medical Center San Diego's (NMCSD) Intensive Care Unit (ICU), perform a code blue drill on a simulation mannequin in the hospital's ICU Sept. 10. The coronavirus (COVID-19) pandemic has changed the way many facets of healthcare are conducted, and NMCSD's ICU has adapted some of their techniques and practices to keep both staff and patients safe while delivering the high-quality healthcare they’ve come to expect. (Photo by Seaman Luke Cunningham, Naval Medical Center San Diego.)

Recommended Content:

Coronavirus | Public Health | Combat Support | Research and Innovation | Nurses Week

“How we are going to use this pandemic to take us to that next level in our nursing profession?”

This was the challenge issued by Navy Rear Adm. Riggs, Defense Health Agency director of research & development, to nurses all across the Defense Health Agency (DHA) enterprise during a recent, virtual-version of the TriService Nursing Research Program (TSRP) course.

TSNRP is a research and evidence-based practice dissemination course. It was created in 2014 to continue the Phyllis J. Verhonick Nursing Research Symposium and the Karen Rieder Research/Federal Nursing poster session, formerly held at the Association for Military Surgeons' annual meeting. This course provides an opportunity for military nurses to disseminate their research and evidence-based practice findings to other nurses across the armed services. Since inception, this course has been an incredible event that connects military nurses with similar scientific and clinical passions, evidence-based practice, and transforms the care delivered to service members and their beneficiaries.

Due to the COVID-19 national emergency, the three-day in-person course was abbreviated to a one-day virtual, which had more than 400 registered participants.

Highlights of this year’s course included recorded presentations from selected presenters, a virtual poster gallery, a virtual speaker gallery, and presentations from each of the services, including Navy Rear Adm. Cynthia Kuehner; Air Force Brig. Gen. Jeannine Ryder and Army Col. Lozay Foots, In addition, Navy Capt. Virginia Blackman, Air Force Col. Jennifer Hatzfeld, and Army Col. Angela Simmons participated. Dr. Patricia Patrician, delivered a keynote presentation presentation focused on “Scientific Mentorship: Your Professional Legacy,” while Riggs, whose lecture, “Nursing during a Pandemic,” was also a keynote presentation. 

Riggs discussed the critical role military nurses played in COVID-19 testing and containment in their local areas, and stressed the role nurses play in education initiatives that include infection prevention strategies, early detection of infection signs and symptoms, emotional support for those in isolation, and the challenging ethical dilemmas that have been identified. She also stressed the need to look at the role of nursing functions and standardizing those activities to develop a set of best practices for pandemics like COVID-19. Riggs pointed out potential changes, including Health Protection Condition Guidance, centralized learning management systems, and Practice Management Guides.

“Hopefully, once we get to the end state, we’ll be a lot better prepared for figuring out where those centralized functions are,” she said. “I would encourage all of you to think through what that will look like.”

Riggs also concluded her presentation by expressing her pride for the work done by military nurses around the world. “I just wanted to say we are so proud of our nurses everywhere, whether it’s in the U.S. or in Europe or across the world,” she said. “I don’t think we’ve dealt of anything of this magnitude…and certainly while nursing is our most valuable asset in times of crisis we need to be very keen to make sure we’re keeping up with each other in terms of physically and emotionally. From the bottom of my heart, I want to thank you all and just know that you harbor my greatest admiration.”

For more information on TSNRP, visit the website; or view the Dissemination Course poster gallery.


TSNRP was established by Congress in 1992 as the country’s first and only Department of Defense program that supports and allows armed forces nurses to conduct military nursing research. The TSNRP mission is to facilitate nursing research to optimize the health of military members and their beneficiaries. TSNRP is located within the Uniformed Services University of the Health Sciences.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA-PI 3200.01: Research and Development (R&D) Enterprise Activity (EA)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): a. Establishes the Defense Health Agency’s (DHA) procedures for the Deputy Assistant Director (DAD), R&D to manage and execute, on behalf of the Assistant Secretary of Defense for Health Affairs (ASD(HA)), the portion of the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation assigned to it (referred to as the “DHP Science and Technology (S&T) Program)”. The DHP S&T Program includes Budget Activities (BAs) 6.1-6.3 and 6.6. The ASD(HA) provides policy, direction, and guidance to inform planning, programming, budgeting, and execution of the DHP RDT&E appropriation in accordance with statute, regulation, and policy in Reference (a). The DAD-R&D, and Component Acquisition Executive (CAE) manage and execute DHP RDT&E Program funds aligned to them on behalf of the ASD(HA). The CAE is responsible for managing BAs 6.4, 6.5, and 6.7 funding, as well as Procurement and Operations and Maintenance funding required to support DHP-funded Acquisition Programs, regardless of acquisition activity. b. Supports the Director, DHA, in developing appropriate DHA management models to maximize efficiencies in the management and execution of DHP RDT&E-funded activities carried out by the Combatant Commands (CCMDs), Services, Uniformed Services University of the Health Sciences (USU), Defense Agencies, and other DoD Components, as applicable. c. Codifies processes to confirm DHP RDT&E funds are applied towards medical priorities and aligned to ASD(HA) policy, direction, and guidance to develop and deliver innovative medical products and solutions that increase the readiness of the DoD medical mission in accordance with Reference (a). d. Supports the following objectives of the R&D EA: (1) Increasing the quantity, quality, and pace of medical research through improved programmatic organization, processes, and oversight. (2) Ensuring DHP RDT&E funded efforts align to ASD(HA) published program guidance that provides resourcing guidance and translates national, departmental, and Service priorities into specific program objectives. (3) Verifying alignment of DHP RDT&E funds to medical priorities and to ASD(HA) policy, direction, and guidance to ensure the development and delivery of medical materiel and knowledge solutions. (4) Facilitating coordination with the CCMDs, Services, USU, Defense Agencies, and other DoD Components, as applicable, to ensure DHP RDT&E funded activities address joint medical capability gaps, and avoid unnecessary duplication.

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

Guidance on the Establishment of a Human Cell, Tissue, and Cellular and Tissue Based Products Program

Policy

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.